Covered recipient · General Payments record
CHARLES M KING
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$23,471.25
- Reported across 236 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $633.88 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $243.46 | 8 |
| Amgen Inc. | $141.93 | 12 |
| GlaxoSmithKline, LLC. | $95.38 | 4 |
| Aurinia Pharma U.S., Inc. | $65.88 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.66 | 2 |
| Sandoz Inc. | $18.97 | 1 |
| Fresenius Kabi USA, LLC | $17.12 | 1 |
| PFIZER INC. | $16.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.83 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077448 | CMS |
| ABBVIE INC. | $18.90 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077450 | CMS |
| ABBVIE INC. | $17.83 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077452 | CMS |
| ABBVIE INC. | $27.08 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077454 | CMS |
| ABBVIE INC. | $88.37 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077456 | CMS |
| ABBVIE INC. | $18.54 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077458 | CMS |
| ABBVIE INC. | $33.81 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077460 | CMS |
| ABBVIE INC. | $21.10 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104077462 | CMS |
| Amgen Inc. | $12.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620428 | CMS |
| Amgen Inc. | $9.60 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620430 | CMS |
| Amgen Inc. | $10.71 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620432 | CMS |
| Amgen Inc. | $18.96 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620434 | CMS |
| Amgen Inc. | $9.16 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620436 | CMS |
| Amgen Inc. | $10.67 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620438 | CMS |
| Amgen Inc. | $9.02 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297944 | CMS |
| Amgen Inc. | $8.45 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620440 | CMS |
| Amgen Inc. | $2.88 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117297946 | CMS |
| Amgen Inc. | $25.06 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620442 | CMS |
| Amgen Inc. | $8.40 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620444 | CMS |
| Amgen Inc. | $16.39 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111620446 | CMS |
| Aurinia Pharma U.S., Inc. | $20.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150684732 | CMS |
| Aurinia Pharma U.S., Inc. | $21.67 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150684734 | CMS |
| Aurinia Pharma U.S., Inc. | $23.42 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150684736 | CMS |
| Fresenius Kabi USA, LLC | $17.12 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146953806 | CMS |
| GlaxoSmithKline, LLC. | $30.45 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116683779 | CMS |
| GlaxoSmithKline, LLC. | $24.68 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116572947 | CMS |
| GlaxoSmithKline, LLC. | $23.32 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116349724 | CMS |
| GlaxoSmithKline, LLC. | $16.93 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116280458 | CMS |
| Novartis Pharmaceuticals Corporation | $19.06 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087050380 | CMS |
| Novartis Pharmaceuticals Corporation | $15.60 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087050384 | CMS |
| PFIZER INC. | $16.48 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131002436 | CMS |
| Sandoz Inc. | $18.97 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089367210 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.